INOVIO Reports Positive Interim Phase 1/2 Trial Results For INO-3107 For Respiratory Papillomatosis

Inovio Pharma Receives FDA Feedback On Submission Of BLA For INO-3107 To Treat RRP

Biotechnology company Inovio Pharmaceuticals, Inc. (INO) announced Tuesday that it has received feedback from the U.S. Food and Drug Administration (FDA) that data from its completed Phase 1/2 trial of INO-3107 for the treatment of RRP could support INOVIO's submission of a BLA for review under the FDA's accelerated approval program.

RTTNews | 665 dagar sedan

INOVIO Says FDA Grants Breakthrough Therapy Designation For INO-3107; Stock Up 15%

Biotechnology company Inovio Pharmaceuticals, Inc. (INO) announced Thursday that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for INO-3107 as a potential treatment for patients with Recurrent Respiratory Papillomatosis (RRP).

RTTNews | 698 dagar sedan

INOVIO Pharma Announces Positive Results From Phase 1b Clinical Trial Evaluating INO-4201

Biotechnology company INOVIO Pharmaceuticals, Inc. (INO) announced Thursday positive results from a Phase 1b clinical trial evaluating INO-4201, a DNA vaccine candidate, as a booster in healthy adult participants who previously received a single injection of Ervebo.

RTTNews | 915 dagar sedan

INOVIO Announces Corporate Reorganization, Including Workforce Reduction, To Reduce Expenses

Biotechnology company INOVIO (INO) announced Tuesday that it has implemented a corporate reorganization designed to extend its cash runway and to focus on key clinical programs with the goal to drive long-term growth.

RTTNews | 1113 dagar sedan

Sensex, Nifty Little Changed In Early Trade

Indian shares were little changed in cautious trade on Wednesday after U.S. President Donald Trump threatened to raise tariffs on Indian goods "very substantially" within 24 hours, citing India's continued purchases of Russian oil.

RTTNews | 1h 4minuter sedan

European Economic News Preview: Germany Factory Orders Data Due

Factory orders and construction purchasing managers' survey data from Germany and retail sales from the euro area are the top economic news due on Wednesday. At 2.00 am ET, Destatis is scheduled to issue Germany's factory orders data for June. Orders are forecast to grow 1.0 percent month-on-month, in contrast to the 1.4 percent fall in May.

RTTNews | 1h 19minuter sedan

Australian Market Maintains Early Gains In Mid-market

The Australian stock market is maintaining its early gains in mid-market moves on Wednesday, extending to the gains in the previous two sessions, with the benchmark S&P/ASX 200 moving above the 8,800 level to all-time record highs, despite the broadly negative cues from Wall Street overnight, with gains across most sectors led by mining and financial stocks.

RTTNews | 2h 10minuter sedan

Asian Markets Track Wall Street Lower

Asian stock markets are trading mostly lower on Wednesday, following the broadly negative cues from Wall Street overnight, amid the ongoing trade concerns following US President Donald Trump's latest comments on tariffs. Trump said he will be announcing new tariffs on semiconductors and chips as well as up to 250 percent on pharmaceuticals imported into the U.S.

RTTNews | 2h 34minuter sedan

EURUSD	1.15769	GBPUSD	1.33041	AUDUSD	0.64869
USDJPY	147.488	USDCAD	1.37734	USDCHF	0.80735

Advertisement

INOVIO Reports Positive Interim Phase 1/2 Trial Results For INO-3107 For Respiratory Papillomatosis